Off-BALANCE? Obesity Drug Model May Need Nearly Universal Part D Plan Participation

Pharma's goal of Medicare coverage for obesity drugs is in question. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Medicare

More from Government Payers